Based on these findings, a related study using 3-month-old APP/PS1 mice was executed to examine the effects of long-term (6-month) treatment with P33 on hippocampal neurogenesis associated with APP-Aβ pathology in this AD model. This evidence concerns the gene APP and Alzheimer disease.